勃林格殷格翰的动态

At Boehringer, we have made a commitment to transforming lives for generations. Hearing from patient advocates who bravely share their journeys and insights on lung cancer for us to understand individual needs is just one example of how we put patients first.? ? Having these open discussions during #LungCancerAwarenessMonth helps build a more supportive and informed community as we reimagine the patient experience. #PatientPoweredProgress? ? #LungCancerAwarenessMonth #LCAM? ?

Early detection saves lives.?? ? This #LungCancerAwarenessMonth, hear from patient advocates as they answer the top questions online about lung cancer diagnosis and the importance of timely access for all. Watch our videos to understand why early screening is crucial. https://lnkd.in/eNEGdW3G ? #LCAM GO2 for Lung Cancer, WALCE APS, Lung Cancer Europe, Respirando con Valor.

Big question: can we find a new way to target, treat and even cure ALK-positive lung cancer? Ground-breaking and innovative lung cancer treatments come from research. It's why Dr David Carbone believes #MoreResearchMoreLife. It's time to focus on CURING ALK fusion-positive lung cancer. #LCAM

#WCLC24: Explore real-world clinical outcomes from patients with HER2-mutant non-small cell lung cancer ?? Read about the latest findings in this systematic literature review. Learn more: https://lnkd.in/duhYwBJ5 Abstract: EP.12D.01, E-Poster #NSCLC #LungCancer International Association for the Study of Lung Cancer

Non-Small Cell Lung Cancer (NSCLC) is one of the most common and challenging types of lung cancer. Therefore, advancing precision medicine is critical to improving outcomes and giving patients hope. By participating in Hightower’s NSCLC Biorepository, you can contribute to research that helps unlock targeted therapies and better treatments for tomorrow. Take part today and help redefine the future of lung cancer care. #HightowerClinical #clinicaltrials #lungcancer

November’s awareness topic is Lung Cancer! Read one of our latest articles that explains why patients with cancer should consider participating in clinical trials for treatment options. Wendy Brooks, a patient with small cell lung cancer spoke to CURE? about her successful experience as a participant in the clinical trial evaluating the antibody-drug conjugate ABBV-706 in small cell lung cancer and why every patient should consider enrolling. Read more: https://ow.ly/jYn450Uh0ta #LungCancer #AwarenessTopic #CUREEducation

Lung cancer care is quickly evolving, and biomarker-based therapies have opened up new possibilities for people with advanced non-small cell lung cancer (#NSCLC). ?? Learn about more about NSCLC from the Lung Cancer Foundation of America: https://amgen.ly/46WAW3V

Paper Authored by The Hormel Institute Scientists Sheds Light on a Mechanism Crucial to Better Understanding and Treating Colorectal Cancer: Learn more ?? https://bit.ly/3OpJSGQ Colorectal cancer is the second most common cause of cancer deaths and is expected to claim more than 53,000 lives in the United States in 2024 alone, according to the American Cancer Society. #colorectralcancer #cancerresearch #biomedicalresearch

Early diagnosis matters. According to the National Cancer Institute, when Lung cancer is detected in Stage 1, the 5-year survival rate can be greater than 90%. Lung cancer screening, which can detect the disease at an earlier stage when it’s more curable, can help save lives. #NoahMedical #GalaxySystem #LungCancer #EarlyDiagnosisMatters Learn more about the impact of early diagnosis: Roadblocks to Lung Cancer Screening: Why Early Detection Is Still Falling Short https://hubs.ly/Q02Yq85K0

This #LungCancerAwarenessMonth, our patient advocates address top questions about lung cancer, providing clarity and hope. Stigma still hinders many from seeking needed support and care. Our interviews reveal true perceptions and the urgent need for change. Together, let's transform the narrative and support those affected. https://bit.ly/40ta9v9 #LCAM GO2 for Lung Cancer, WALCE APS, Lung Cancer Europe